SCHEMBL14853898

SCHEMBL14853898

COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(C)ncnc32)C(O)C1O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 6/20 0.73
▸ P2RX3 P56373 4/20 0.73
▸ P2RY2 P41231 2/20 0.73
▸ P2RX1 P51575 2/20 0.73
▸ ALDH1A1 P00352 2/20 0.73
▸ P2RX2 Q9UBL9 2/20 0.73
▸ SRC P12931 1/20 0.73
▸ P2RX4 Q99571 1/20 0.73
▸ SMN1; SMN2 Q16637 1/20 0.73
▸ MACROD2 A1Z1Q3 1/20 0.68
▸ SIRT6 Q8N6T7 1/20 0.68
▸ MACROD1 Q9BQ69 1/20 0.68
▸ TRPM2 O94759 1/20 0.68
▸ RNASEL Q05823 1/20 0.62
▸ KDM4E B2RXH2 1/20 0.61
▸ MEN1 O00255 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ CYP2D6 P10635 1/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ KMT2A Q03164 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29995120 0.93 P2RY1 (0.74) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL13853911 0.93 P2RY1 (0.74) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL10295499 0.91 P2RY1 (0.71) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL5560007 0.90 P2RY1 (0.91) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL22652873 0.90 P2RY1 (0.91) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL13548820 0.90 P2RY1 (0.91) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL13853893 0.90 P2RY1 (0.91) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL18022428 0.90 P2RY1 (0.91) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL13550314 0.90 P2RY1 (0.91) P2RY1P2RX3P2RY2P2RX1ALDH1A1
SCHEMBL14853625 0.90 P2RY1 (0.72) P2RY1P2RX3P2RY2P2RX1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013052523-A1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF modeRNA Therapeutics (US) 2013-04-11 — — WO disclosed
Send feedback